AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
EDUCATION OF MEDICINAL CHEMISTS IN DEPARTMENTS OF MEDICINAL CHEMISTRY(USA)
Authors: GANELLIN CR MITSCHER LA TOPLISS JG
Citation: Cr. Ganellin et al., EDUCATION OF MEDICINAL CHEMISTS IN DEPARTMENTS OF MEDICINAL CHEMISTRY(USA), Medicinal research reviews, 18(2), 1998, pp. 121-137
GLOSSARY OF TERMS USED IN MEDICINAL CHEMISTRY (IUPAC RECOMMENDATIONS 1998)
Authors: WERMUTH G GANELLIN CR LINDBERG P MITSCHER LA
Citation: G. Wermuth et al., GLOSSARY OF TERMS USED IN MEDICINAL CHEMISTRY (IUPAC RECOMMENDATIONS 1998), Pure and applied chemistry, 70(5), 1998, pp. 1129-1143
BIS-QUINOLINIUM CYCLOPHANES AS POTENT NONPEPTIDIC BLOCKERS OF THE APAMIN-SENSITIVE SKCA CHANNELS
Authors: ROSA JC DUNN PM GALANAKIS D GANELLIN CR JENKINSON DH
Citation: Jc. Rosa et al., BIS-QUINOLINIUM CYCLOPHANES AS POTENT NONPEPTIDIC BLOCKERS OF THE APAMIN-SENSITIVE SKCA CHANNELS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 2814-2814
NEUROCHEMICAL AND BEHAVIORAL-EFFECTS OF CIPROXIFAN, A POTENT HISTAMINE H-3-RECEPTOR ANTAGONIST
Authors: LIGNEAU X LIN JS VANNIMERCIER G JOUVET M MUIR JL GANELLIN CR STARK H ELZ S SCHUNACK W SCHWARTZ JC
Citation: X. Ligneau et al., NEUROCHEMICAL AND BEHAVIORAL-EFFECTS OF CIPROXIFAN, A POTENT HISTAMINE H-3-RECEPTOR ANTAGONIST, The Journal of pharmacology and experimental therapeutics, 287(2), 1998, pp. 658-666
BIS-QUINOLINIUM CYCLOPHANES - (1,4)-DIBENZENA-1,5(1,4)-DIQUINOLINACYCLODECAPHANE (UCL-1684), THE FIRST NANOMOLAR, NONPEPTIDIC BLOCKER OF THE APAMIN-SENSITIVE CA2-ACTIVATED K+ CHANNEL()
Authors: ROSA JC GALANAKIS D GANELLIN CR DUNN PM JENKINSON DH
Citation: Jc. Rosa et al., BIS-QUINOLINIUM CYCLOPHANES - (1,4)-DIBENZENA-1,5(1,4)-DIQUINOLINACYCLODECAPHANE (UCL-1684), THE FIRST NANOMOLAR, NONPEPTIDIC BLOCKER OF THE APAMIN-SENSITIVE CA2-ACTIVATED K+ CHANNEL(), Journal of medicinal chemistry, 41(1), 1998, pp. 2-5
MODULATION OF GABA(A) RECEPTORS AND INHIBITORY SYNAPTIC CURRENTS BY THE ENDOGENOUS CNS SLEEP REGULATOR CIS-9,10-OCTADECENOAMIDE (COA)
Authors: LEES G EDWARDS MD HASSONI AA GANELLIN CR GALANAKIS D
Citation: G. Lees et al., MODULATION OF GABA(A) RECEPTORS AND INHIBITORY SYNAPTIC CURRENTS BY THE ENDOGENOUS CNS SLEEP REGULATOR CIS-9,10-OCTADECENOAMIDE (COA), British Journal of Pharmacology, 124(5), 1998, pp. 873-882
BIS-QUINOLINIUM CYCLOPHANES - A NOVEL CLASS OF POTENT BLOCKERS OF THEAPAMIN-SENSITIVE CA2-ACTIVATED K+ CHANNEL()
Authors: ROSA JC BECKWITHHALL BM GALANAKIS D GANELLIN CR DUNN PM JENKINSON DH
Citation: Jc. Rosa et al., BIS-QUINOLINIUM CYCLOPHANES - A NOVEL CLASS OF POTENT BLOCKERS OF THEAPAMIN-SENSITIVE CA2-ACTIVATED K+ CHANNEL(), Bioorganic & medicinal chemistry letters, 7(1), 1997, pp. 7-10
INTERNATIONAL UNION OF PHARMACOLOGY .13. CLASSIFICATION OF HISTAMINE-RECEPTORS
Authors: HILL SJ GANELLIN CR TIMMERMAN H SCHWARTZ JC SHANKLEY NP YOUNG JM SCHUNACK W LEVI R HAAS HL
Citation: Sj. Hill et al., INTERNATIONAL UNION OF PHARMACOLOGY .13. CLASSIFICATION OF HISTAMINE-RECEPTORS, Pharmacological reviews, 49(3), 1997, pp. 253-278
POTENTIAL HIV PROTEASE INHIBITORS - PREPARATION OF DI-N-ALKYLATED 2-AMINODEOXY-DERIVATIVE, 6-AMINODEOXY-DERIVATIVE, AND 2,6-AMINODEOXY-DERIVATIVE OF D-GLUCOSE BY DIRECT DISPLACEMENT AND BY A NOVEL REDUCTIVE-ALKYLATION PROCEDURE
Authors: CAI JQ DAVISON BE GANELLIN CR THAISRIVONGS S WIBLEY KS
Citation: Jq. Cai et al., POTENTIAL HIV PROTEASE INHIBITORS - PREPARATION OF DI-N-ALKYLATED 2-AMINODEOXY-DERIVATIVE, 6-AMINODEOXY-DERIVATIVE, AND 2,6-AMINODEOXY-DERIVATIVE OF D-GLUCOSE BY DIRECT DISPLACEMENT AND BY A NOVEL REDUCTIVE-ALKYLATION PROCEDURE, Carbohydrate research, 300(2), 1997, pp. 109-117
RATIONAL DESIGN OF BUTABINDIDE, THE FIRST INHIBITOR OF THE CHOLECYSTOKININ (CCK-8) INACTIVATING PEPTIDASE
Authors: GANELLIN CR ROSE C VARGAS F FACCHINETTI P BOURGEAT P BAMBAL R BISHOP PB CHAN SMT MOORE ANJ SCHWARTZ JC
Citation: Cr. Ganellin et al., RATIONAL DESIGN OF BUTABINDIDE, THE FIRST INHIBITOR OF THE CHOLECYSTOKININ (CCK-8) INACTIVATING PEPTIDASE, British Journal of Pharmacology, 122, 1997, pp. 189-189
MODULATION OF GABA(A) RECEPTORS AND INHIBITORY SYNAPTIC CURRENTS IN CULTURED RAT CORTICAL-NEURONS BY THE ENDOGENOUS BRAIN LIPID CIS-9,10-OCTADECENOAMIDE (COA)
Authors: LEES G GANELLIN CR
Citation: G. Lees et Cr. Ganellin, MODULATION OF GABA(A) RECEPTORS AND INHIBITORY SYNAPTIC CURRENTS IN CULTURED RAT CORTICAL-NEURONS BY THE ENDOGENOUS BRAIN LIPID CIS-9,10-OCTADECENOAMIDE (COA), British Journal of Pharmacology, 122, 1997, pp. 273-273
ON THE CONCEPT OF A BIVALENT PHARMACOPHORE FOR SKCA CHANNEL BLOCKERS - SYNTHESIS, PHARMACOLOGICAL TESTING, AND RADIOLIGAND BINDING-STUDIES ON MONO-QUINOLINIUM, BIS-QUINOLINIUM, AND TRIS-QUINOLINIUM COMPOUNDS
Authors: GALANAKIS D GANELLIN CR DUNN PM JENKINSON DH
Citation: D. Galanakis et al., ON THE CONCEPT OF A BIVALENT PHARMACOPHORE FOR SKCA CHANNEL BLOCKERS - SYNTHESIS, PHARMACOLOGICAL TESTING, AND RADIOLIGAND BINDING-STUDIES ON MONO-QUINOLINIUM, BIS-QUINOLINIUM, AND TRIS-QUINOLINIUM COMPOUNDS, Archiv der pharmazie, 329(12), 1996, pp. 524-528
VOCATIONAL-TRAINING FOR MEDICINAL CHEMISTS - VIEWS FROM INDUSTRY
Authors: BUSSE WD GANELLIN CR MITSCHER LA
Citation: Wd. Busse et al., VOCATIONAL-TRAINING FOR MEDICINAL CHEMISTS - VIEWS FROM INDUSTRY, European journal of medicinal chemistry, 31(10), 1996, pp. 747-760
CHARACTERIZATION AND INHIBITION OF A CHOLECYSTOKININ-INACTIVATING SERINE PEPTIDASE
Authors: ROSE C VARGAS F FACCHINETTI P BOURGEAT P BAMBAL RB BISHOP PB CHAN SMT MOORE ANJ GANELLIN CR SCHWARTZ JC
Citation: C. Rose et al., CHARACTERIZATION AND INHIBITION OF A CHOLECYSTOKININ-INACTIVATING SERINE PEPTIDASE, Nature, 380(6573), 1996, pp. 403-409
THE SYNTHESIS AND SOME PHARMACOLOGICAL ACTIONS OF THE ENANTIOMERS OF THE K-CHANNEL BLOCKER CETIEDIL()
Authors: ROXBURGH CJ GANELLIN CR SHINER MAR BENTON DCH DUNN PM AYALEW Y JENKINSON DH
Citation: Cj. Roxburgh et al., THE SYNTHESIS AND SOME PHARMACOLOGICAL ACTIONS OF THE ENANTIOMERS OF THE K-CHANNEL BLOCKER CETIEDIL(), Journal of Pharmacy and Pharmacology, 48(8), 1996, pp. 851-857
SYNTHESIS, MOLECULAR MODELING, AND K-BLOCKING ACTIVITY OF DEQUALINIUMANALOGS HAVING SEMIRIGID LINKERS( CHANNEL)
Authors: ROSA JC GALANAKIS D GANELLIN CR DUNN PM
Citation: Jc. Rosa et al., SYNTHESIS, MOLECULAR MODELING, AND K-BLOCKING ACTIVITY OF DEQUALINIUMANALOGS HAVING SEMIRIGID LINKERS( CHANNEL), Journal of medicinal chemistry, 39(21), 1996, pp. 4247-4254
SYNTHESIS AND QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP OF A NOVELSERIES OF SMALL-CONDUCTANCE CA2-ACTIVATED K+ CHANNEL BLOCKERS RELATEDTO DEQUALINIUM()
Authors: GALANAKIS D DAVIS CA GANELLIN CR DUNN PM
Citation: D. Galanakis et al., SYNTHESIS AND QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP OF A NOVELSERIES OF SMALL-CONDUCTANCE CA2-ACTIVATED K+ CHANNEL BLOCKERS RELATEDTO DEQUALINIUM(), Journal of medicinal chemistry, 39(2), 1996, pp. 359-370
A NOVEL SERIES OF (PHENOXYALKYL)IMIDAZOLES AS POTENT H-3 RECEPTOR HISTAMINE-ANTAGONISTS
Authors: GANELLIN CR FKYERAT A BANGANDERSEN B ATHMANI S TERTIUK W GARBARG M LIGNEAU X SCHWARTZ JC
Citation: Cr. Ganellin et al., A NOVEL SERIES OF (PHENOXYALKYL)IMIDAZOLES AS POTENT H-3 RECEPTOR HISTAMINE-ANTAGONISTS, Journal of medicinal chemistry, 39(19), 1996, pp. 3806-3813
SYNTHESIS AND PHARMACOLOGICAL TESTING OF DEQUALINIUM ANALOG AS BLOCKERS OF THE APAMIN-SENSITIVE CA2-ACTIVATED K+ CHANNEL - VARIATION OF THELENGTH OF THE ALKYLENE CHAIN()
Authors: GALANAKIS D GANELLIN CR MALIK S DUNN PM
Citation: D. Galanakis et al., SYNTHESIS AND PHARMACOLOGICAL TESTING OF DEQUALINIUM ANALOG AS BLOCKERS OF THE APAMIN-SENSITIVE CA2-ACTIVATED K+ CHANNEL - VARIATION OF THELENGTH OF THE ALKYLENE CHAIN(), Journal of medicinal chemistry, 39(18), 1996, pp. 3592-3595
DISCRIMINATION BETWEEN SUBTYPES OF APAMIN-SENSITIVE CA2-ACTIVATED K+ CHANNELS BY GALLAMINE AND A NOVEL BIS-QUATERNARY QUINOLINIUM CYCLOPHANE, UCL-1530()
Authors: DUNN PM BENTON DCH ROSA JC GANELLIN CR JENKINSON DH
Citation: Pm. Dunn et al., DISCRIMINATION BETWEEN SUBTYPES OF APAMIN-SENSITIVE CA2-ACTIVATED K+ CHANNELS BY GALLAMINE AND A NOVEL BIS-QUATERNARY QUINOLINIUM CYCLOPHANE, UCL-1530(), British Journal of Pharmacology, 117(1), 1996, pp. 35-42
PHOTOLABILE DERIVATIVES OF I-125 APAMIN - DEFINING THE STRUCTURAL CRITERIA REQUIRED FOR LABELING HIGH AND LOW-MOLECULAR-MASS POLYPEPTIDES ASSOCIATED WITH SMALL-CONDUCTANCE CA2-ACTIVATED K+ CHANNELS()
Authors: WADSWORTH JDF DOORTY KB GANELLIN CR STRONG PN
Citation: Jdf. Wadsworth et al., PHOTOLABILE DERIVATIVES OF I-125 APAMIN - DEFINING THE STRUCTURAL CRITERIA REQUIRED FOR LABELING HIGH AND LOW-MOLECULAR-MASS POLYPEPTIDES ASSOCIATED WITH SMALL-CONDUCTANCE CA2-ACTIVATED K+ CHANNELS(), Biochemistry, 35(24), 1996, pp. 7917-7927
SYNTHESIS AND SQAR OF DEQUALINIUM ANALOGS AS K- INVESTIGATIONS ON THEROLE OF THE 4-AMINO GROUP( CHANNEL BLOCKERS )
Authors: GALANAKIS D DAVIS CA HERRERO BD GANELLIN CR DUNN PM JENKINSON DH
Citation: D. Galanakis et al., SYNTHESIS AND SQAR OF DEQUALINIUM ANALOGS AS K- INVESTIGATIONS ON THEROLE OF THE 4-AMINO GROUP( CHANNEL BLOCKERS ), Bioorganic & medicinal chemistry letters, 5(6), 1995, pp. 559-562
SYNTHESIS AND AUTHENTICATION OF IODOAZIDOPHENPYRAMINE, A PHOTOAFFINITY REPORTER LIGAND PREVIOUSLY USED FOR HISTAMINE H-1-RECEPTOR LABELING
Authors: SORBA G TERTIUK W GANELLIN CR
Citation: G. Sorba et al., SYNTHESIS AND AUTHENTICATION OF IODOAZIDOPHENPYRAMINE, A PHOTOAFFINITY REPORTER LIGAND PREVIOUSLY USED FOR HISTAMINE H-1-RECEPTOR LABELING, Archiv der pharmazie, 328(9), 1995, pp. 677-680
NEW 3,4-O-ISOPROPYLIDENE DERIVATIVES OF D-GLUCOPYRANOSIDES AND L-GLUCOPYRANOSIDES
Authors: CAI JQ DAVISON BE GANELLIN CR THAISRIVONGS S
Citation: Jq. Cai et al., NEW 3,4-O-ISOPROPYLIDENE DERIVATIVES OF D-GLUCOPYRANOSIDES AND L-GLUCOPYRANOSIDES, Tetrahedron letters, 36(36), 1995, pp. 6535-6536
SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF DEQUALINIUM ANALOGSAS K- INVESTIGATIONS ON THE ROLE OF THE CHARGED HETEROCYCLE( CHANNEL BLOCKERS )
Authors: GALANAKIS D DAVIS CA HERRERO BD GANELLIN CR DUNN PM JENKINSON DH
Citation: D. Galanakis et al., SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF DEQUALINIUM ANALOGSAS K- INVESTIGATIONS ON THE ROLE OF THE CHARGED HETEROCYCLE( CHANNEL BLOCKERS ), Journal of medicinal chemistry, 38(4), 1995, pp. 595-606
Risultati: 1-25 | 26-35